Navigation Links
SCOLR Pharma, Inc. Announces Resignation of CEO Daniel O. Wilds
Date:12/16/2008

BOTHELL, Wash., Dec. 16 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext: DDD) today announced that Daniel O. Wilds had resigned as Chief Executive Officer of the Company and as a member of its Board of Directors effective December 12, 2008.

Michael N. Taglich, Chairman of the Board of SCOLR Pharma, said, "On behalf of the Board of Directors and SCOLR's entire organization, I would like to thank Dan for his more than five years of vision and leadership. We are focused on advancing our extended release CDT(R) ibuprofen towards an FDA submission in 2009. We believe we are well positioned to achieve advantageous alliances with major pharmaceutical companies and other potential partners. We continue to manage our cash to maximize resources appropriately in the current environment. Our development work continues on a positive track and I believe that advancing our core proprietary clinical programs will result in increased shareholder value and make us a stronger organization."

The Company will be managed by its existing executive management team on an interim basis.

About SCOLR Pharma

Based in Bothell, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company. SCOLR Pharma's corporate objective is to combine its formulation expertise and its patented CDT platform to develop novel pharmaceutical, over-the-counter (OTC), and nutritional products. Our CDT drug delivery platform is based on multiple issued and pending patents and other intellectual property for the programmed release or enhanced performance of active pharmaceutical ingredients and nutritional products. For more information on SCOLR Pharma, please call 425.368.1050 or visit http://www.scolr.com/.

This press release contains forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities L
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. SCOLR Pharma, Inc. Announces Positive Top-Line Results From Pivotal Clinical Trial Evaluating Efficacy of Extended-Release Ibuprofen
2. SCOLR Pharma, Inc. Schedules Third Quarter 2008 Financial Results Conference Call for November 7, 2008 at 11:30 A.M. Eastern
3. SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation
4. Why Do Drugs Cost So Much? and why are we so darn sick?: New Book Reveals Inner Workings of Big Pharma, Asks Hard Questions About Our Health
5. Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
6. Legislative and Regulatory Outlook - 2009 and Beyond for Pharma, Biotech Players
7. TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD
8. GeoPharma, Inc. to Present at the EdgeWater Research Investor Conference
9. Go Healthy Announces Agreement in Principle With Dynamic Investments LTD for a Rule 144-A $100 Million Covered Bond Placement
10. Zeus Announces Product-Line Expansion with Insulated PEEK(TM) Wire
11. White Mountains Re Announces Management Changes -- Chokel to Retire and Remain Risk Advisor at WTM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...irstCall/ -- Care Investment Trust Inc. (NYSE: ...hat its Board of Directors has declared a dividend... is payable on December 22, 2009 to common shareho...out Care Investment Trust ,, Care Investment T...company investing in healthcare-related real estat...
(Date:12/4/2009)...swire/ -- Medithrive, Inc. has won the Patient,s C...ay Area by popular vote conducted by the online we...hs in operation, the SF Bay community has selected...ng medicinal marijuana. ,, The rapid rise and...dispensary which caters to the consumer, provides ...
(Date:12/4/2009)...-USNewswire/ -- The American Association of Homes ...nate for ensuring that the Community Living and S...e final health reform legislation . The CLASS prov...rs, people with disabilities and their caregivers....eform bill that will make it affordable to care fo...
(Date:12/4/2009)...Newswire/ -- The large, two-day free health clinic...nics (NAFC) in Kansas City on Wednesday and Thursd...o is uninsured and has not seen a doctor recently....e preventive primary care. ,, "Many people who...nts this fall in Houston, New Orleans and Little R...
(Date:12/4/2009)...Newswire/ -- Pamela Bowen, Chief Information Offic...ist for the "Chief Innovation Officer" Appy Award ...r of cloud computing. Appy Award recipients are no...rce CRM or the Force.com platform in bringing new ...ng, partner, service, support or IT organizations....
Breaking Medicine News(10 mins):Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
..., The Association for Gerontology in Higher Educ...ntological Society of America , will hold its 35t...ence February 26March 1, 2009, at the Crowne Pla... about gerontological and geriatric education and ...
..., CARLSBAD, Calif., Jan. 30 Beautiful skin wi...you may actually save money on skin care,this year...tress level and,cleaning out your cabinets. , ...skin. With the ten thrifty tips, this host of "Ski...
..., RED BANK, New Jersey, BRUSSELS and MELBOURNE...obal corporate,website. With over a century of exp...otective solutions is now rethinking its presence ... The site includes corporate information with ...
..., Three New Studies Initiated in Other Oncology Se...0 GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN)...ense Application (BLA) to the U.S. Food and Drug A...erapies. If approved, ofatumumab would be the firs...
..., SAN DIEGO and LISLE, Ill., Jan. 30 SpineMar...that partners with hospitals and,physicians to dev... a,partnership with Healthplace America to deliver...Surgery Benefit(TM). As a result,of their affilia...
..., MIAMI, Jan. 30 Physicians Healthcare Managemen...developer of health maintenance organizations (HMO...hyshield Insurance Exchange, a licensed medical ma...ongress and a new administration in Washington. H...
Other Medicine News:Health News:Teaching about financial crisis among Gerontology Meeting's highlights 2Health News:Ten Thrifty Tips for Radiant Skin 2Health News:Ten Thrifty Tips for Radiant Skin 3Health News:Ansell Limited Launching a New Global Website 2Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 2Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 3Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 4Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 5Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 6Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 7Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 8Health News:SpineMark Partners With Healthplace America to Offer Access to Top Quality Spinal Care 2Health News:SpineMark Partners With Healthplace America to Offer Access to Top Quality Spinal Care 3Health News:SpineMark Partners With Healthplace America to Offer Access to Top Quality Spinal Care 4Health News:Phyhealth Provides Update to Shareholders 2Health News:Phyhealth Provides Update to Shareholders 3Health News:Phyhealth Provides Update to Shareholders 4
(Date:12/4/2009)..., , INDIANAPOLIS, Dec. 4 /PRNewswire-...ion (FDA) today approved Zyprexa® (olanzapine... schizophrenia and manic or mixed episodes associa...-17 years old. ,, The updated Zyprexa label st...n the increased potential for weight gain and hype...
(Date:12/4/2009)..., , OMAHA, Neb., Dec. 4 Am...editation by the Accreditation Commission for Heal...ices. For nearly 15 years, Amber Pharmacy has prov...ices to meet the unique needs of specialized condi...ers of services to transplant programs. They work ...
(Date:12/4/2009)..., , STREAMWOOD, Ill., Dec. 4 /PRNewswire/...f CT, MRI and PET/CT systems and service programs ... to announce it has received The Joint Commission,...onally-recognized, prestigious gold seal of approv...Imaging accreditation is system-wide for its mobil...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Amber Pharmacy Earns Accreditation From ACHC 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Gut worms may protect against house dust mite allergy 58400 1Gut worms may protect against house dust mite allergy 58400 2Gut worms may protect against house dust mite allergy 58400 3Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 1Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 2Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 3Canker disease in eucalyptus in the Basque Country 10128 1Canker disease in eucalyptus in the Basque Country 10128 2Canker disease in eucalyptus in the Basque Country 10128 3Canker disease in eucalyptus in the Basque Country 10128 4
... ANTIPOLIS, France, Nov. 7 NicOx S.A.,(Eurolist: ...xploratory,pharmacodynamic study for naproxcinod u...ere presented yesterday at the American Heart,Asso...ida. Naproxcinod is,the first compound in the COX-...ammatory agents and is in clinical development for...
..., Nov. 7 Vital Therapies, Inc. (VTI), announced,t...) (Extracorporeal Liver,Assist Device) System were...e Study of Liver Diseases (AASLD) Annual Meeting, ...Abstract (#91), "Interim results of Randomized Con...Liver Disease," was presented in a parallel s...
Other Medicine Technology:NicOx' Naproxcinod ABPM Data Presented at American Heart Association 2NicOx' Naproxcinod ABPM Data Presented at American Heart Association 3NicOx' Naproxcinod ABPM Data Presented at American Heart Association 4Vital Therapies Announces Presentation of ELAD(R) 'Artificial Liver' Data at American Association for the Study of Liver Diseases 2007 Annual Meeting 2
AGC Revision knee
Advance Stemmed Medial-Pivot Knee
AGC Dual Articular Knee
Scorpio TS Single Axis Revision Knee System
Medicine Products: